I agree that this site is using cookies. You can find further informations here.
X
Grundman, Michael
161  results:
Search for persons X
?
1

A pilot study to evaluate the effect of CT1812 treatment on..:

van Dyck, Christopher H. ; Mecca, Adam P. ; O'Dell, Ryan S....
Alzheimer's Research & Therapy.  16 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
2

Promoting diversity in clinical trials: insights from plann..:

Wise-Brown, Alexandria ; Brangman, Sharon A. ; Henderson, J. Neil...
eClinicalMedicine.  73 (2024)  - p. 102693 , 2024
Link: https://doi.org/10.1016/..
 
?
3

A phase 1b randomized clinical trial of CT1812 to measure A..:

LaBarbera, Kelsie M. ; Sheline, Yvette I. ; Izzo, Nicholas J....
Translational Neurodegeneration.  12 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
4

EMPOWER AD: A Novel, Patient-Centric, Longitudinal, Clinica..:

Grundman, Michael ; Mearns, Elizabeth S. ; Raimundo, Karina...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
5

A Phase 1 Clinical Trial of IL‐2 in Patients with Alzheimer..:

Faridar, Alireza ; Eid, Abdulmunaim M ; Thome, Aaron D...
Alzheimer's & Dementia.  19 (2023)  S21 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
6

INVOKE‐2: Phase 2 trial of a TREM2 mAb in Early AD:

Romano, Gary ; Mayorga, Arthur ; Simmons, Adam...
Alzheimer's & Dementia.  19 (2023)  S13 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
7

A phase 1 open-label pilot study of low-dose interleukine-2..:

Faridar, Alireza ; Eid, Abdulmunaim M. ; Thome, Aaron D....
Translational Neurodegeneration.  12 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
8

ALUMNI AD Study Design: Evaluation of Subcutaneous Gantener..:

Seleri, Sheila ; Brangman, Sharon ; Henderson, J. Neil...
Neurology.  100 (2023)  17_supplement_2 - p. , 2023
Link: https://doi.org/10.1212/..
 
?
9

Sigma-2 Receptors—From Basic Biology to Therapeutic Target:..:

Lizama, Britney N. ; Kahle, Jennifer ; Catalano, Susan M....
International Journal of Molecular Sciences.  24 (2023)  7 - p. 6251 , 2023
Link: https://doi.org/10.3390/..
 
?
10

Author Correction: Safety and efficacy of anti-tau monoclon..:

Dam, Tien ; Boxer, Adam L. ; Golbe, Lawrence I....
Nature Medicine.  29 (2022)  11 - p. 2955-2956 , 2022
Link: https://doi.org/10.1038/..
 
?
11

Safety and efficacy of anti-tau monoclonal antibody gosuran..:

Dam, Tien ; Boxer, Adam L. ; Golbe, Lawrence I....
Nature Medicine.  27 (2021)  8 - p. 1451-1457 , 2021
Link: https://doi.org/10.1038/..
 
?
12

Value-Generating Exploratory Trials in Neurodegenerative De..:

Friedman, Lauren G. ; McKeehan, Nicholas ; Hara, Yuko...
Neurology.  96 (2021)  20 - p. 944-954 , 2021
Link: https://doi.org/10.1212/..
 
?
13

Preclinical and clinical biomarker studies of CT1812: A nov..:

Izzo, Nicholas J. ; Yuede, Carla M. ; LaBarbera, Kelsie M....
Alzheimer's & Dementia.  17 (2021)  8 - p. 1365-1382 , 2021
Link: https://doi.org/10.1002/..
 
?
14

The clinical promise of biomarkers of synapse damage or los..:

the Synaptic Health Endpoints Working Group ; Colom-Cadena, Martí ; Spires-Jones, Tara...
Alzheimer's Research & Therapy.  12 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
15

Real-World Treatment Patterns and Characteristics Among Pat..:

Aigbogun, Myrlene Sanon ; Cloutier, Martin ; Gauthier-Loiselle, Marjolaine...
Journal of Alzheimer's Disease.  77 (2020)  3 - p. 1181-1194 , 2020
Link: https://doi.org/10.3233/..
 
1-15